This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

CNS Honored Guest Lecturer Dr. Ralph Dacey Speaks On Impact Of IMRI On Oct. 10

Stocks in this article: IM IMRS

Describes how VISIUS ® Surgical Theatre adds value in brain tumor management

WINNIPEG, Oct. 10, 2012 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS) (TSX: IM) ("IMRIS" or the "Company") is announcing that the effective impact of high field strength intraoperative MRI (iMRI) for brain tumor management was the focus of the Congress of Neurological Surgeons (CNS) honored guest lecture.

Dr. Ralph G. Dacey Jr., the current Henry G. and Edith R. Schwartz professor and chairman of the department of neurosurgery at the Washington University School of Medicine in St. Louis, spoke on this topic at the Annual Meeting of CNS on Wednesday, Oct. 10, in Chicago.

Dr. Dacey, a CNS past president and treasurer, discussed how integration of iMRI with the IMRIS VISIUS ® Surgical Theatre at the Barnes-Jewish & Washington University Neuroscience Center has fulfilled the intention of improving the precision, efficacy and safety of neurosurgical procedures. Since it was installed in 2008 more than 700 procedures have been conducted in the three-room (two operating rooms and magnet bay) theatre where the patient remains in a fixed position while the iMRI moves to the patient.

"I believe this technology and its systematic application is safe and in our procedures has added significant value to patient surgical care," he said. "Our work and studies show that iMRI can be done safely and with high volume to achieve the surgical objective the first time and effectively prevent additional surgeries to complete tumor removal."

Currently serving as the president of the Society for Neurological Surgeons, Dr. Dacey discussed during his presentation the positive impact of iMRI on extent of resection (EOR). He said that studies show increased EOR has demonstrated better patient outcomes. Referring to his data published in 2011, he said, 93 percent of iMRI glioma cases achieved gross or near total resection compared to 65 percent for non-iMRI cases in the same timeframe. Even in GBMs (glioblastoma multiforme), among the most invasive tumors, he said, an increase in gross total resection from 24 to 57 percent and an increase in progression free survival is noted.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs